Compound Detail
CHEMBL17350
TRAXOPRODIL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL17350 |
| Name | TRAXOPRODIL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | QEMSVZNTSXPFJA-HNAYVOBHSA-N |
11
Targets
19
Activities
2
Assay Types
6
PK Parameters
20
Publications
3
Known Names
3
Indications
1
Mechanisms
Molecular Properties
327.4
MW (Da)
2.80
ALogP
4
HBA
3
HBD
63.9
PSA (Ų)
0.81
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Glutamate NMDA receptor; GRIN1/GRIN2B antagonist | ANTAGONIST | Glutamate NMDA receptor; GRIN1/GRIN2B | ✓ | ✓ |
Indications
Depressive Disorder, Major Parkinson Disease Stroke
Activity Summary
IC50 16 meas. best 8.15
Ki 3 meas. best 8.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 2B CHEMBL311 | Ki | 8.34 | 8.34 | 4.6 | 1 |
| Glutamate [NMDA] receptor CHEMBL2094124 | IC50 | 8.15 | 8.15 | 7.0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B CHEMBL311 | IC50 | 8.15 | 7.7967 | 7.0 | 3 |
| Glutamate NMDA receptor CHEMBL1907608 | IC50 | 7.99 | 7.975 | 10.2 | 2 |
| Glutamate receptor ionotropic, NMDA 2B CHEMBL1904 | IC50 | 7.96 | 7.545 | 11.0 | 2 |
| Glutamate NMDA receptor; GRIN1/GRIN2B CHEMBL1907603 | Ki | 7.96 | 7.96 | 11.0 | 1 |
| Glutamate [NMDA] receptor CHEMBL2094124 | Ki | 7.96 | 7.96 | 11.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Glutamate NMDA receptor; GRIN1/GRIN2B CHEMBL1907603 | IC50 | 7.52 | 7.52 | 30.0 | 1 |
| Glutamate NMDA receptor; Grin1/Grin2b CHEMBL2096666 | IC50 | 7.14 | 7.14 | 73.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.37 | 5.37 | 4250.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 5.24 | 4.975 | 5700.0 | 2 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 27.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 27.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 37.0 | mL.min-1.g-1 | Homo sapiens |
| Fu | 0.63 | - | Homo sapiens |
| MRT | 2.6 | hr | Homo sapiens |
| T1/2 | 3.7 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 7636876 | 10.1021/jm00016a017 | Unchecked | 3 |
| 9544217 | 10.1021/jm9707986 | Rattus norvegicus | 2 |
| 17766106 | 10.1016/j.bmcl.2007.08.014 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 17290978 | 10.1021/jm060420k | Glutamate receptor ionotropic, NMDA 2B | 2 |
| 15225705 | 10.1016/j.bmcl.2004.05.053 | Mus musculus | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 7636876 | 10.1021/jm00016a017 | Glutamate NMDA receptor | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 21524576 | 10.1016/j.bmcl.2011.03.117 | Glutamate receptor ionotropic, NMDA 2B | 2 |
| 7636876 | 10.1021/jm00016a017 | Adrenergic receptor alpha-1 | 2 |
| 9544217 | 10.1021/jm9707986 | Mus musculus | 1 |
| 12639560 | 10.1016/s0960-894x(02)01060-0 | Glutamate NMDA receptor; GRIN1/GRIN2B | 1 |
| 9544217 | 10.1021/jm9707986 | Unchecked | 1 |
| 12617901 | 10.1016/s0960-894x(03)00007-6 | Glutamate [NMDA] receptor | 1 |
| 36870623 | 10.1016/j.bmcl.2023.129213 | Glutamate receptor ionotropic, NMDA 2B | 1 |
| 10464027 | 10.1021/jm990199u | Glutamate NMDA receptor; Grin1/Grin2b | 1 |
Data from ChEMBL 36 via Core Engine